Considering the notable effects of miR-187 on a high variety of malignancies, it seems necessary to investigate the miR-187 actions in ATLL patients.miR-18a-3p was highlighted as a tumor-suppressive agent through its inhibitory effect on K-Ras [74]. The gene discussed is KRAS; the disease is neoplasm.